Beyond Air, Inc. Common Stock (XAIR) is a publicly traded Healthcare sector company. As of October 14, 2026, XAIR trades at $2.14 with a market cap of $2.27M and a P/E ratio of -0.21. XAIR moved +0.91% today. Year to date, XAIR is -86.12%; over the trailing twelve months it is -95.84%. Its 52-week range spans $2.16 to $152.00. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces XAIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for XAIR, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.14 |
| Market Cap | $2.27M |
| P/E Ratio | -0.21 |
| EPS | $-13.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $152.00 |
| 52-Week Low | $2.16 |
| Volume | 38.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.69M |
| Net Income | $-34.41M |
| Gross Margin | 4.18% |
1 analysts cover XAIR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.